Evidence map›Paper›PMID 35813896›Full record

ReviewJournal of clinical and translational research2022

Artificial intelligence and lymphedema: State of the art.

Abdullah S Eldaly, Francisco R Avila, Ricardo A Torres-Guzman, Karla Maita, John P Garcia, Luiza Palmieri Serrano, Antonio J Forte

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Journal of clinical and translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07485465 (The Role of Chat GPT in the Diagnosis and Treatment of Lymphedema), which is not on this map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07485465 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Role of Chat GPT in the Diagnosis and Treatment of Lymphedema

Typeobservational_patient_registrySponsorFatih Sultan Mehmet Training and Research HospitalRan2026 to 2026Enrolled25ConditionsLymphedema, Artificial Intelligence (AI)Armsa domain-specific, custom-trained large language model for the differential diagnosis and treatment planning of lymphedema, lipedema, and venous insufficiency
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. AI Quality Standards in Health Care: Rapid Umbrella Review.Journal of medical Internet research · 2024
    Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Abdullah S EldalyDivision of Plastic Surgery, Mayo Clinic, Jacksonville, Florida.
Francisco R AvilaDivision of Plastic Surgery, Mayo Clinic, Jacksonville, Florida.
Ricardo A Torres-GuzmanDivision of Plastic Surgery, Mayo Clinic, Jacksonville, Florida.
Karla MaitaDivision of Plastic Surgery, Mayo Clinic, Jacksonville, Florida.
John P GarciaDivision of Plastic Surgery, Mayo Clinic, Jacksonville, Florida.
Luiza Palmieri SerranoDivision of Plastic Surgery, Mayo Clinic, Jacksonville, Florida.
Antonio J ForteDivision of Plastic Surgery, Mayo Clinic, Jacksonville, Florida.
WinnMed · USJacksonville College · USMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lymphedema practice is facing many challenges. Some of these challenges include eradication of tropical lymphedema, preclinical diagnosis of cancer-related lymphedema, and delivery of appropriate individualized care. The past two decades have witnessed an increasing implementation of artificial intelligence (AI) in health-care services. The nature of the challenges facing the lymphedema practice is suitable for AI applications. Aim: The aim of this study was to explore the current AI applications in lymphedema prevention, diagnosis, and management and investigate the potential future applications. Methods and Results: Four databases were searched: PubMed, Scopus, Web of Science, and EMBASE. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis as our basis of organization. Our analysis showed that several domains of AI, including machine learning (ML), fuzzy models, deep learning, and robotics, were successfully implemented in lymphedema practice. ML can guide the eradication campaigns of tropical lymphedema by estimating disease prevalence and mapping the risk areas. Robotic-assisted surgery for gynecological cancer was associated with a lower risk for the lower limb lymphedema. Several feasible models were described for the early detection and diagnosis of lymphedema. The proposed models are more accurate, sensitive, and specific than current methods in practice. ML was also used to guide and monitor patients during the rehabilitation exercises. Conclusion: AI offers a variety of solutions to the most challenging problems in lymphedema practice. Further, implementation into the practice can revolutionize many aspects of lymphedema prevention, diagnosis, and management. Relevance to Patients: Lymphedema is a chronic debilitating disease that is affecting millions of patients. Developing new modalities for prevention, early diagnosis, and treatment are critical to improve the outcomes. AI offers a variety of solutions for some of the complexities of lymphedema management. In this systematic review, we summarize and discuss the latest AI advances in lymphedema practice.

Indexed as

artificial intelligencelymphatic filariasislymphedemamachine learningtropical lymphedema

Identifiers

PMID35813896
PMCPMC9260343
OpenAlexW4285046851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.